124 related articles for article (PubMed ID: 21453705)
1. Ubiquitin C-terminal hydrolase-L3 regulates Smad1 ubiquitination and osteoblast differentiation.
Kim JY; Lee JM; Cho JY
FEBS Lett; 2011 Apr; 585(8):1121-6. PubMed ID: 21453705
[TBL] [Abstract][Full Text] [Related]
2. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin carboxyl-terminal hydrolase l3 promotes insulin signaling and adipogenesis.
Suzuki M; Setsuie R; Wada K
Endocrinology; 2009 Dec; 150(12):5230-9. PubMed ID: 19837878
[TBL] [Abstract][Full Text] [Related]
4. Developmental regulation of ubiquitin C-terminal hydrolase isozyme expression during spermatogenesis in mice.
Kwon J; Wang YL; Setsuie R; Sekiguchi S; Sakurai M; Sato Y; Lee WW; Ishii Y; Kyuwa S; Noda M; Wada K; Yoshikawa Y
Biol Reprod; 2004 Aug; 71(2):515-21. PubMed ID: 15084487
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin dimers control the hydrolase activity of UCH-L3.
Setsuie R; Sakurai M; Sakaguchi Y; Wada K
Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
[TBL] [Abstract][Full Text] [Related]
6. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
7. Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation.
Xie J; Gu J
J Cell Mol Med; 2015 Aug; 19(8):1814-24. PubMed ID: 25818514
[TBL] [Abstract][Full Text] [Related]
8. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
9. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha.
Li W; Yu B; Li M; Sun D; Hu Y; Zhao M; Cui CB; Hou S
Biochem Biophys Res Commun; 2010 Jan; 391(2):1228-33. PubMed ID: 20006586
[TBL] [Abstract][Full Text] [Related]
10. SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells.
Ouyang X; Fujimoto M; Nakagawa R; Serada S; Tanaka T; Nomura S; Kawase I; Kishimoto T; Naka T
J Cell Physiol; 2006 May; 207(2):428-36. PubMed ID: 16419040
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.
Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ
Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537
[TBL] [Abstract][Full Text] [Related]
12. UCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein.
Xie M; Han Y; Yu Q; Wang X; Wang S; Liao X
J Alzheimers Dis; 2016; 49(2):353-63. PubMed ID: 26444754
[TBL] [Abstract][Full Text] [Related]
13. The deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel.
Butterworth MB; Edinger RS; Ovaa H; Burg D; Johnson JP; Frizzell RA
J Biol Chem; 2007 Dec; 282(52):37885-93. PubMed ID: 17967898
[TBL] [Abstract][Full Text] [Related]
14. Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase.
Kokabu S; Ohte S; Sasanuma H; Shin M; Yoneyama K; Murata E; Kanomata K; Nojima J; Ono Y; Yoda T; Fukuda T; Katagiri T
Mol Endocrinol; 2011 Mar; 25(3):474-81. PubMed ID: 21239611
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
16. The Transcription Factor EB (TFEB) Regulates Osteoblast Differentiation Through ATF4/CHOP-Dependent Pathway.
Yoneshima E; Okamoto K; Sakai E; Nishishita K; Yoshida N; Tsukuba T
J Cell Physiol; 2016 Jun; 231(6):1321-33. PubMed ID: 26519689
[TBL] [Abstract][Full Text] [Related]
17. Regulation of neuropeptide Y Y1 receptor expression by bone morphogenetic protein 2 in C2C12 myoblasts.
Kurebayashi N; Sato M; Fujisawa T; Fukushima K; Tamura M
Biochem Biophys Res Commun; 2013 Oct; 439(4):506-10. PubMed ID: 24025680
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
[TBL] [Abstract][Full Text] [Related]
19. Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor.
Liu H; Liu Y; Viggeswarapu M; Zheng Z; Titus L; Boden SD
J Bone Miner Res; 2011 May; 26(5):1122-32. PubMed ID: 21542012
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin C-Terminal Hydrolase L1 regulates myoblast proliferation and differentiation.
Gao H; Hartnett S; Li Y
Biochem Biophys Res Commun; 2017 Oct; 492(1):96-102. PubMed ID: 28803986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
